ArticleJournal of clinical medicine2026

Mid-Term Impact of Kampo Goreisan in Patients with Congestive Heart Failure Receiving Tolvaptan-Incorporated Medical Therapy.

Yuki Hida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.